JPM vs RVMD Stock Comparison

JPM currently leads RVMD in this stock comparison, with AIQ scores of 65 vs 55. The clearest difference is quality, while RVMD has the stronger value profile.

Market data as of Nov 15, 2026 market close· AIQ score gap 10 points
JPM
Financial Services
vs
RVMD
Healthcare
JPM
JPMorgan Chase & Co.
Leads
Price
$346
Day move
+0.98%
AIQ Score
65/100
Best edge
Quality
Sector
Financial Services
RVMD
Revolution Medicines, Inc.
Price
$172
Day move
-2.3%
AIQ Score
55/100
Best edge
Value
Sector
Healthcare

What is the main difference between JPM and RVMD?

JPM leads the current stock comparison as JPMorgan Chase & Co., with the clearest separation coming from quality and the broader AIQ evidence mix.

AlgovestIQ AIQ Comparison

JPMorgan Chase & Co. vs Revolution Medicines, Inc.

Data as of Nov 15, 2026· market close· Cross-sector · Financial Services vs Healthcare· Coverage 65/66 fields· High confidence
AIQ VerdictFragileAIQ Comparison Conviction 4/10

JPM leads

JPM leads by 10 AIQ points, primarily on Quality and Risk Resilience, having only recently taken the lead back from RVMD. Wall Street currently favors RVMD on target upside.

Fragile: 3 of 6 evidence groups support JPM, the lead recently changed hands, and its current signal state is conflicted.

Evidence agreement: 3 of 6Comparison trend: Reversed
JPM

JPMorgan Chase & Co.

Leads
AIQ Score
65/100
AIQ Edge Score
8/10
RVMD

Revolution Medicines, Inc.

AIQ Score
55/100
AIQ Edge Score
5/10

The Algovestiq AIQ Score currently favors JPM over RVMD, 65 versus 55 as of Nov 15, 2026. JPM's advantage is driven primarily by stronger quality and risk resilience, while RVMD holds the stronger value profile. JPM also shows the stronger technical structure relative to its 50-day moving average, though analyst target upside currently favors RVMD. 3 of 6 covered evidence groups favor JPM today, and the comparison is rated Fragile on stability: only 3 of 6 covered evidence groups agree. JPM lead: Reversed — RVMD led by 1 AIQ points 30 sessions ago; JPM now leads by 10.

Compare JPMorgan Chase & Co. and Revolution Medicines, Inc. across the Algovestiq AIQ Score, valuation, quality, momentum, risk, technicals and analyst expectations.

Currently unavailable

Performance over time

Total return with distributions reinvested, from daily closes.

JPM
+138.4%
RVMD
+456.0%

Total return comparison

Growth of $10,000, distributions reinvested

JPM $23,841 · RVMD $55,595

Split-adjusted closes; each distribution is reinvested at the close on its ex-dividend date. Taxes and trading costs are not modeled.

Compare JPM and RVMD against another ticker

Open a multi-ticker workspace without changing this focused pair page.

Basic: 2 symbols·Explorer: 3 symbols·Pro and Premium: 5 symbols·Your limit: 2

AIQ Factor Divergence

Where the two separate, on the four dimensions behind the AIQ Score. Bars read outward from a shared zero: further from the centre is a wider gap.

JPM advantage
0
RVMD advantage
  • Quality86 vs 43
    JPM +43
  • Value10 vs 39
    RVMD +29
  • Risk Resilience87 vs 59
    JPM +28
  • Momentum70 vs 73
    Even

3 of 6 evidence groups favor JPM. JPM’s edge is concentrated in quality and risk resilience; RVMD keeps a meaningful value edge.

What changed since the last close

Latest scored session 2026-11-13, compared against the prior scored session 2026-11-12.

JPM0 AIQ

Largest factor move: Momentum +1, not enough on its own to move the overall score.

New signals

  • Drawdown Recovery Signal — bullish, risk_regime, long horizon (-9.0%)
  • MACD Histogram Expanding Bullish — bullish, momentum, short horizon
RVMD+1 AIQ

Largest factor move: Momentum +2

New signals

  • BB Lower Band Breach — bullish, volatility, short horizon
  • Stochastic Oversold Bounce — bullish, momentum, short horizon

JPM's lead narrowed by 1 AIQ point in the latest session.

Deeper signal detail for each name lives on its own signals page — JPM and RVMD both carry a full feed there.

The central trade-off

JPM (JPMorgan Chase & Co.): the stronger current systematic profile, led by quality and risk resilience.

RVMD (Revolution Medicines, Inc.): the counter-case, on value, valuation, analyst expectations — but at materially higher volatility, 71% against 27.4%.

The AIQ Score and Wall Street therefore point in different directions on this pair.

Which one fits your objective

The same two names rank differently depending on what you are optimizing for. All six reads are shown at once — none of them is hidden behind a toggle.

Balanced

JPM

JPM on the overall AIQ Score, which weights Quality and Value most heavily.

Growth

RVMD

RVMD on combined revenue and EPS growth.

Value

RVMD

RVMD on the peer-relative Value factor, by 29 points.

Momentum

Even

The two are level on Momentum.

Lower downside

JPM

JPM on Risk Resilience, by 28 points.

Analyst upside

RVMD

RVMD on implied upside to the consensus price target.

AIQ vs Wall Street

The model and the Street disagree here: AIQ favors JPM, analyst targets favor RVMD. That disagreement is the most useful thing on this page.

MeasureJPMRVMDNote
Implied upside to target+7.8%+52.3%RVMD has more room
Target dispersion+30.3%+53.7%Lower is tighter analyst agreement
ConsensusBuyBuyContext, not a primary driver
Analysts covering2625Higher coverage generally improves confidence

The two are measuring different things. The AIQ Score reads current fundamentals, valuation, trend and risk; analyst targets price forward expectations. A divergence of this kind is either a contrarian opportunity or a sign the model is missing something already priced in — it is worth resolving before acting on either.

Analyst targets are expectations, not predictions. Dispersion matters as much as the midpoint.

AIQ Agreement Matrix

3 of 6 covered evidence groups favor JPM. A wide gap backed by one group is a weaker case than a narrow gap backed by five.

Evidence groupFavorsReading
AIQ ScoreJPM65 vs 55
FundamentalsEvenEPS growth -27.6% vs 37.9%; TTM ROE 4.1% vs -17%; gross margin 63.2% vs 95.2%; operating margin 28.2% vs -8.5%
ValuationRVMDValue 10 vs 39
TechnicalsJPMPrice vs 50-day 1.7% vs -11.4%; vs 200-day 6.6% vs 7.8%
Risk ResilienceJPMRisk Resilience 87 vs 59
Analyst expectationsRVMDTarget upside 7.8% vs 52.3%

✓ agrees with the overall verdict · ✕ points the other way. Groups marked “not covered” lack data on one or both of JPM and RVMD and are excluded from the count.

AIQ Decision Stability

Fragile

The conclusion is sensitive to small changes. Treat the lead as provisional and watch the flip conditions below.

  • The AIQ gap is moderate at 10 points.
  • Only 3 of 6 covered evidence groups agree. (argues the conclusion is provisional)
  • The lead has already changed hands inside the comparison window. (argues the conclusion is provisional)
  • The leader is throwing conflicting signals. (argues the conclusion is provisional)

Stability combines the score gap, how broadly the evidence agrees, how steady the lead has been across daily snapshots, the current signal state on both names, and analyst dispersion on JPM.

How the comparison changed

120 daily snapshots · May 27 – Nov 13

JPM lead: Reversed — RVMD led by 1 AIQ points 30 sessions ago; JPM now leads by 10.

May 27JPM leads above the line · RVMD leads belowNov 13
Today
JPM +10
65 vs 55
7 sessions ago
JPM +7
64 vs 57
30 sessions ago
RVMD +1
63 vs 64
90 sessions ago
RVMD +5
64 vs 69

The lead has not changed hands in this window.

AIQ Signal Divergence

Only the signals that bear on the head-to-head. A conflicted name is carrying bullish and bearish rules at the same time — the technical evidence is not pointing one way.

JPMConflicted

6 bullish / 1 bearish / 1 neutral, conflicted

Only JPM

  • Bollinger Band Squeeze — neutral, volatility, short horizon (5.9%)
  • Drawdown Recovery Signal — bullish, risk_regime, long horizon (-9.0%)
  • EMA Ribbon Expansion Bullish — bullish, trend, medium horizon
  • Low Volume Rally Warning — bearish, volume, short horizon (0.65x)
  • MACD Histogram Expanding Bullish — bullish, momentum, short horizon
  • TRIX Bullish Signal — bullish, momentum, short horizon
  • Uptrend Structure Active — bullish, trend, long horizon
RVMDConflicted

3 bullish / 3 bearish / 1 neutral, conflicted

Only RVMD

  • ATR Expansion - Breakout Mode — neutral, volatility, short horizon (5.84%)
  • BB Lower Band Breach — bullish, volatility, short horizon
  • Beta Spike Warning — bearish, risk_regime, long horizon
  • Distribution Pattern — bearish, volume, medium horizon (1.12x)
  • MACD Histogram Expanding Bearish — bearish, momentum, short horizon
  • Stochastic Oversold Bounce — bullish, momentum, short horizon

Both carry 1 more signal that do not separate them: Golden Cross Active.

JPM leads the comparison while carrying a conflicted signal state, which is one reason the stability rating is not higher.

Price vs model alignment

Whether the latest session's price move confirms what the model did over the same session, or contradicts it.

JPMNo material change

Neither the price nor the AIQ Score moved enough in the latest session to confirm or contradict the other (price +0.98%, AIQ 0 points).

RVMDDivergence

Price is down while the AIQ Score moved up 1 points over the same session — price and model disagree (price -2.3%, AIQ +1 points).

What would flip this result

A state, not a forecast. These are the specific, observable changes that would reverse the verdict — not a price prediction.

  1. 1RVMD closes the Quality gap — currently 43 points behind, the largest single contributor to JPM's edge.
  2. 2RVMD's Beta Spike Warning resolves — a bearish risk_regime rule currently active against it.
  3. 3JPM's conflicting signal state resolves bearish — it currently carries 6 bullish and 1 bearish rules at once.
  4. 4A market regime shift would change the factor readings behind both scores; a rotation toward or away from quality, value or momentum could move the result.

The full evidence

Every number behind the verdict. The leader is called above each group so you are not left to solve it from the table.

Fundamentals

Split
MetricJPMRVMD
Revenue growth (YoY)-7.6%0%
EPS growth (YoY)-27.6%37.9%
Gross margin63.2%95.2%
Operating margin28.2%-8.5%
Return on equity (TTM)4.1%-17%
Debt to equity3.320.27

Performance

Split across windows
MetricJPMRVMD
1 week (5 sessions)3.5%-10.4%
1 month (20 sessions)1.9%-3.2%
3 months (63 sessions)-4.1%-18.7%
6 months (126 sessions)16.2%18.3%
Year to date7.4%116.3%
1 year (252 sessions)8%161.7%

Technicals

JPM has the stronger structure
MetricJPMRVMD
RSI (14)56.139.7
ADX (14)1817.6
Price vs 50-day1.7%-11.4%
Price vs 200-day6.6%7.8%
Volatility (1M, annualized)27.4%71%

Risk

JPM is the more resilient
MetricJPMRVMD
Beta0.781.3
Sharpe ratio0.441.69
Sortino ratio0.613.54
Max drawdown-15.5%-25%
Current drawdown-5.2%-22.1%
Annualized volatility22.7%68.7%
Value at risk (95%)-2.4%-4%

Straight answers

Each answer is regenerated from the current snapshot, not written once and left to age.

Which is better, JPM or RVMD?

On the Algovestiq AIQ Score, JPM is the stronger of the two as of Nov 15, 2026, scoring 65 against RVMD's 55. The edge comes from quality and risk resilience. RVMD is not without a case — it holds the better value profile, which matters more if that is the objective you are optimizing for. This is a systematic score, not a recommendation: it ranks the two on the same evidence, it does not know your holding period or tax position.

Is JPM or RVMD the better buy right now?

JPM carries the stronger systematic profile as of Nov 15, 2026, and the comparison is rated Fragile — 3 of 6 covered evidence groups agree. A Fragile rating means the conclusion is sensitive: only 3 of 6 covered evidence groups agree. Treat the lead as provisional.

Why does the AIQ Score favor JPM over RVMD?

The composite weights Quality, Value, Momentum and Risk Resilience. JPM leads Quality by 43 points; RVMD leads Value by 29 points; JPM leads Risk Resilience by 28 points. Where the two split, the factor with the larger weight carries the result.

Which has more analyst upside, JPM or RVMD?

Analyst price targets imply +7.8% upside for JPM and +52.3% for RVMD, so the Street currently favors RVMD. That points the opposite way to the AIQ Score, which favors JPM. The two are measuring different things: the model reads current fundamentals, valuation, trend and risk; the Street is pricing forward expectations. A divergence of this kind is either a contrarian opportunity or a sign the model is missing something the analysts have already priced — it is the single most useful row on this page to investigate. Analyst targets are expectations, not predictions, and dispersion matters as much as the midpoint.

Which is better value, JPM or RVMD?

RVMD is the better-valued of the two on the peer-relative Value factor. RVMD on the peer-relative Value factor, by 29 points. The Value factor reads valuation relative to sector peers and to the company's own fundamental quality, so it is not the same as simply having the lower multiple.

Which has stronger growth, JPM or RVMD?

RVMD on combined revenue and EPS growth. Growth here is measured on reported revenue and earnings, not on forward estimates — it describes what the businesses have delivered, not what the Street expects next.

Which has stronger momentum, JPM or RVMD?

The two are level on Momentum. Momentum is one of the four weighted factors in the AIQ composite. It has documented persistence over three- to twelve-month horizons, which makes it a timing input rather than a reason to hold something indefinitely.

Which is riskier, JPM or RVMD?

JPM is the more resilient of the two, so the other name carries the higher downside risk. JPM on Risk Resilience, by 28 points. Risk Resilience is a weighted factor in the composite; position sizing usually responds to it more usefully than the buy/avoid decision does.

Is JPM more profitable than RVMD?

The profitability evidence is mixed: gross margin 63.2% vs 95.2%; operating margin 28.2% vs -8.5%; ttm roe 4.1% vs -17%. JPM leads on two measures and RVMD on one measure, and there is no single profitability composite that resolves the split — which of the two reads as "more profitable" depends on whether you weight pricing power or operating leverage.

Is JPM's lead over RVMD getting stronger or weaker?

JPM lead: Reversed — RVMD led by 1 AIQ points 30 sessions ago; JPM now leads by 10. This is measured from 120 daily comparison snapshots between 2026-05-27 and 2026-11-13. The lead has not changed hands in that window.

What would change the JPM vs RVMD verdict?

The result is a state, not a forecast, so it changes when the underlying evidence changes. Concretely: RVMD closes the Quality gap — currently 43 points behind, the largest single contributor to JPM's edge; RVMD's Beta Spike Warning resolves — a bearish risk_regime rule currently active against it; JPM's conflicting signal state resolves bearish — it currently carries 6 bullish and 1 bearish rules at once; a market regime shift would change the factor readings behind both scores; a rotation toward or away from quality, value or momentum could move the result.

What do the current signals say about JPM and RVMD?

JPM: 6 bullish / 1 bearish / 1 neutral, conflicted. RVMD: 3 bullish / 3 bearish / 1 neutral, conflicted. A conflicted state means bullish and bearish rules are active on the same name at once — the technical evidence is not pointing one way, and a decision taken on it carries more timing risk. The most decision-relevant rule on JPM is Golden Cross Active (bullish, long horizon). On RVMD it is Golden Cross Active (bullish, long horizon).

Compare JPM and RVMD with others

Continue your research

This page answers which of the two. These answer the questions on either side of it.

How this comparison is scored

The Algovestiq AIQ Score composites four factors — Quality, Value, Momentum and Risk, each carrying a fixed weight. Sentiment is reported separately as SentimentPulse and is not folded into the composite. Scores refresh every trading day, and this page regenerates from the latest snapshot rather than being written once.

The verdict names a leader, states how broadly six independent evidence groups agree, and rates how durable that conclusion is given the score gap, its recent trajectory and the current signal state on both names.

How to use side-by-side comparison →

This comparison is informational and educational, not investment advice. AIQ scores update daily; re-check after earnings, guidance or macro data that materially changes either name’s factor profile.